Page 3 - Biofoundry Services News Today

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Profitability This table compares Codex DNA and Rapid […]

Codex DNA, Inc. (NASDAQ:DNAY – Get Rating) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,980,000 shares, a growth of 37.5% from the March 15th total of 1,440,000 shares. Based on an average daily volume of 380,900 shares, the days-to-cover ratio is […]

Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Earnings & Valuation This table compares Codex DNA […]

Scientific Industries (OTCMKTS:SCND – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, valuation, profitability, institutional ownership, risk and analyst recommendations. Profitability This table compares Scientific Industries and […]

Codex DNA (NASDAQ:DNAY – Get Rating) issued its quarterly earnings results on Tuesday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.37) by ($0.06), MarketWatch Earnings reports. Codex DNA updated its FY 2022 guidance to EPS. DNAY traded down $0.76 on Thursday, hitting $5.30. 1,160,977 shares of […]